BD Biosciences, Systems & Reagents Anti-Lambda APC-H7, Catalog Number 656157. Product Usage: Intended for in vitro flow cytometric immunophenotyping of hematologic disorders. Recall
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Anti-Lambda APC-H7, Catalog Number 656157. Product Usage: Intended for in vitro flow cytometric immunophenotyping of hematologic disorders.
Brand
BD Biosciences, Systems & Reagents
Lot Codes / Batch Numbers
Lot numbers 4155632 with expiry date of 2015-06-30. Lot 42889687 was not shipped to customers.
Products Sold
Lot numbers 4155632 with expiry date of 2015-06-30. Lot 42889687 was not shipped to customers.
BD Biosciences, Systems & Reagents is recalling Anti-Lambda APC-H7, Catalog Number 656157. Product Usage: Intended for in vitro flow cytometri due to Two lots of the Anti-Lambda APC-H7 antibody are contaminated with CD38 antibody.. This is a Class I recall, indicating a high risk of serious health consequences or death. Based on FDA medical device enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Two lots of the Anti-Lambda APC-H7 antibody are contaminated with CD38 antibody.
Recommended Action
Per FDA guidance
Healthcare providers and patients should stop using the device and contact the manufacturer for further instructions. Report problems to FDA MedWatch.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 11, 2026